First-line antiretroviral drug discontinuations in children

about

Discontinuation of Efavirenz in Paediatric Patients: Why do Children Switch?

P2860

Q47404336-BAE31CE5-3838-4786-915B-8910DE764D6C

P2860

First-line antiretroviral drug discontinuations in children

Item

http://www.wikidata.org/entity/Q36278763

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

First-line antiretroviral drug discontinuations in children

@ast

First-line antiretroviral drug discontinuations in children

@en

type

Item

label

First-line antiretroviral drug discontinuations in children

@ast

First-line antiretroviral drug discontinuations in children

@en

prefLabel

First-line antiretroviral drug discontinuations in children

@ast

First-line antiretroviral drug discontinuations in children

@en

P1476

First-line antiretroviral drug discontinuations in children

@en

P2093

Ehimario U Igumbor

http://www.w3.org/2001/XMLSchema#string

Karl-Günter Technau

http://www.w3.org/2001/XMLSchema#string

Kathryn Stinson

http://www.w3.org/2001/XMLSchema#string

Melony Fortuin-de Smidt

http://www.w3.org/2001/XMLSchema#string

Reneé de Waal

http://www.w3.org/2001/XMLSchema#string

P2860

Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach

Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa

Success with antiretroviral treatment for children in Kigali, Rwanda: experience with health center/nurse-based care.

Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012

Increases in regimen durability associated with the introduction of tenofovir at a large public-sector clinic in Johannesburg, South Africa

Safety and tolerability of antiretroviral therapy among HIV-infected children and adolescents in Uganda.

Low incidence of abacavir hypersensitivity reaction among African children initiating antiretroviral therapy.

Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children.

Abacavir hypersensitivity reaction.

Safety, tolerability and effectiveness of generic HAART in HIV-infected children in South India.

P304

e0169762

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0169762

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28192529

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

5305232

http://www.w3.org/2001/XMLSchema#string

First-line antiretroviral drug discontinuations in children

about

P2860

P2860

First-line antiretroviral drug discontinuations in children

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932